|
|
| | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one Basic information |
| Product Name: | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one | | Synonyms: | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one;Flurazepam-d10 Dihydrochloride (1.0mg/mL in Methanol);Flurazepam-d10 Dihydrochloride (1mg/ml in Acetonitrile) | | CAS: | 1795033-32-7 | | MF: | C21H23ClFN3O | | MW: | 387.88 | | EINECS: | | | Product Categories: | | | Mol File: | 1795033-32-7.mol | ![1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one Structure](CAS/20180601/GIF/1795033-32-7.gif) |
| | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one Chemical Properties |
| solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly), Water (Slightly) | | form | Solid | | color | White to Pale Yellow |
| | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one Usage And Synthesis |
| Description | Flurazepam-d10 (CRM) is intended for use as an internal standard for the quantification of flurazepam by GC- or LC-MS. Flurazepam is structurally categorized as a benzodiazepine. It produces anxiolytic and sedative properties that have been implemented clinically in the treatment of insomnia but also carry a potential for misuse.1,2 This product is intended for research and forensic applications. | | Uses | Labelled Flurazepam (F500800). Flurazepam is used as an sedative, hypnotic. This is a controlled substance (depressant). | | References | 1. Bertisch, S.M., Herzig, S.J., Winkelman, J.W., et al. National use of prescription medications for insomnia: NHANES 1999-2010 Sleep 37(2),343-349(2014). 2. Griffiths, R.R., and Johnson, M.W. Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds J. Clin. Psychiatry 66(Suppl 9),31-41(2005). |
| | 1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one Preparation Products And Raw materials |
|